Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Hospira Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (273)
Cancellation by sponsor (53)

Date

2024 (9)
2023 (7)
2022 (9)
2021 (30)
2020 (31)
2019 (28)
2018 (1)
2017 (5)
2016 (5)
2015 (4)
2014 (7)
2013 (14)
2012 (1)
2011 (10)
2010 (2)
2009 (16)
2008 (23)
2007 (61)
2006 (8)
2005 (23)
2004 (9)
2001 (2)
2000 (2)
1998 (3)
1997 (4)
1996 (1)
1994 (4)
1992 (4)
1991 (3)

Results for "[search-keyword]"

Search

Sponsor content

326 result(s) found, displaying 101 to 110

Hospira Cytarabine injection 2 g/20 mL vial (CA) Cancelled under Section 30(1)(c) of the Act

16 December 2019

Cancellation by sponsor

Requested by Hospira Australia Pty Ltd
Hospira Cytarabine Injection solution 2 g/20 mL vial Cancelled under Section 30(1)(c) of the Act

16 December 2019

Cancellation by sponsor

Requested by Hospira Australia Pty Ltd
Hospira Cytarabine Injection 1 g/10 mL vial (CA) Cancelled under Section 30(1)(c) of the Act

16 December 2019

Cancellation by sponsor

Requested by Hospira Australia Pty Ltd
Hospira Cytarabine Injection solution 1 g/10 mL vial Cancelled under Section 30(1)(c) of the Act

16 December 2019

Cancellation by sponsor

Requested by Hospira Australia Pty Ltd
Hospira Cytarabine Injection solution 100 mg/1 mL vial Cancelled under Section 30(1)(c) of the Act

16 December 2019

Cancellation by sponsor

Requested by Hospira Australia Pty Ltd
Cytarabine Injection 2 g/20 mL vial USA Cancelled under Section 30(1)(c) of the Act

16 December 2019

Cancellation by sponsor

Requested by Hospira Australia Pty Ltd
Hospira Cytarabine Injection, 100 mg/5 mL vial Cancelled under Section 30(1)(c) of the Act

16 December 2019

Cancellation by sponsor

Requested by Hospira Australia Pty Ltd
Hospira Cytarabine Injection solution 500 mg/5 mL vial Cancelled under Section 30(1)(c) of the Act

16 December 2019

Cancellation by sponsor

Requested by Hospira Australia Pty Ltd
Hospira Erythromycin Lactobionate for Intravenous Infusion, 1 g/vial Cancelled under Section 30(1)(c) of the Act

16 December 2019

Cancellation by sponsor

Requested by Hospira Australia Pty Ltd
Ondansetron Injection USP 40 mg/20 mL Multi Dose Vial Cancelled under Section 30(1)(c) of the Act

16 December 2019

Cancellation by sponsor

Requested by Hospira Australia Pty Ltd

Pages

First page
Previous page
…
Page 7
Page 8
Page 9
Page 10
Current page 11
Page 12
Page 13
Page 14
Page 15
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.